NANEXA — Nanexa AB Share News
0.000.00%
Last trade - 00:00- SEK2.01bn
- SEK1.95bn
- SEK36.15m
Brief: Nanexa Reports Q1 Revenue of SEK 8.173 Million
Brief: Nanexa Q4 Revenue SEK 0.8 Million
Brief: Nanexa Signs Evaluation Agreement With Novo Nordisk
Brief: Nanexa, VitriVax Resolve Patent Infringement Lawsuit
Brief: Nanexa July-Sept EBIT Loss Widens To SEK 11.9 Mln
Brief: Nanexa Signs Evaluation Agreement With Pharma Company
Brief: Nanexa, Vitrivax Reach Agreement In Principle
Brief: Nanexa Develops Long-Acting Formulation
Brief: Nanexa Signs Evaluation Deal With Pharmaceutical Company
Brief: Nanexa Q2 EBIT Loss Widens To SEK 15.9 Mln
Brief: Nanexa Q2 EBIT Loss Widens To SEK 15.9 Million
Brief: Nanexa Receives Extended GMP-Certificate For New Pilot Plant
Brief: Nanexa Extends Collaboration Agreement With Applied Materials
Brief: European Patent Office Grants Nanexa’s Pharmashell® Patent
Brief: Nanexa Q1 EBIT Loss Widens To SEK 12.3 Mln
Brief: Positive Development In Nanexa’s Patent Litigation Case
Brief: Nanexa Q4 EBIT Loss Widens To SEK 13.0 Million
Brief: Nanexa Granted Patent In U.S
Brief: Nanexa Q3 EBIT Loss Widens To SEK 7.9 Mln